Policy and procedure for the nurse performance of bone marrow aspirate and trephine biopsy
Review date - 13th November 2022
This is the most current document and should be used until a revised version is in place
Use and monitoring of intravenous Unfractionated Heparin (UFH) in adults
Review date - 15th January 2023
This is the most current document and should be used until a revised version is in place
Guideline for the management of suspected Neutropenic sepsis induced in Oncology/ Haematology Patients
Review date - 6th July 2024
This is the most current document and should be used until a revised version is in place
Policy and procedures for adult intrathecal cytotoxic chemotherapy
Review date - 12th August 2024
This is the most current document and should be used until a revised version is in place
Guideline for the management of venous thromboembolism and including the management of patients receiving low molecular weight heparin
Review date - 11th August 2021
This is the most current document and should be used until a revised version is in place
Warfarin and other oral anticoagulants
Review date - 12th August 2023
This is the most current document and should be used until a revised version is in place
Management of adult patients with sickle cell disease
Review date - 11th August 2021
This is the most current document and should be used until a revised version is in place
Reducing Venous Thromboembolism (VTE) in Adult Patients
This is the most current document and should be used until a revised version is in place
Blood Transfusion- pathway
Guideline for Management and Prevention of Acute Tumour Lysis Syndrome in Haematological Malignancies
Review date - 7th October 2022
This is the most current document and should be used until a revised version is in place
Coagulopathy in COVID-19: Recommendations for Laboratory Testing and Thromboprophylaxis
Review date - 12th November 2022
This is the most current document and should be used until a revised version is in place
Vascular Access Device Service - Standard Operating Procedures
Review date - 30th March 2025
This is the most current document and should be used until a revised version is in place
Use of Andexanet Alfa for Reversing Anticoagulation from Apixaban or Rivaroxaban - Guideline
Review date - 13th April 2024
This is the most current document and should be used until a revised version is in place
